Home › Hereditary Angioedemas › California
Hereditary Angioedemas clinical trials in California
5 studies for Hereditary Angioedemas are looking for participants at sites in California.
Cities in California
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
- Study Site, San Diego
- Study Site, Walnut Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266805STOP-HAE: A Phase 3 Study of ADX-324 in HAE
- ADARx Clinical Site, San Diego
- ADARx Clinical Site, Santa Monica
- ADARx Clinical Site, Walnut Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06960213Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
- ADARx Clinical Site, San Diego
- ADARx Clinical Site, Walnut Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07428499Donidalorsen Treatment in Children With Hereditary Angioedema
- Ionis Investigative Site, Santa Monica
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 2, 2026 · NCT07298447Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
- Cedars Sinai Medical Center, Los Angeles
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Feb 27, 2026 · NCT06919003From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.